Owen R J, Bell G D, Desai M, Moreno M, Gant P W, Jones P H, Linton D
National Collection of Type Cultures, Central Public Health Laboratory, London.
J Med Microbiol. 1993 Jan;38(1):6-12. doi: 10.1099/00222615-38-1-6.
Biotypes, ribosomal RNA gene restriction patterns (ribopatterns), whole-cell protein patterns and plasmid profiles of paired Helicobacter pylori isolates from 17 patients were examined. Each pair comprised a pre- and a post-treatment isolate; nine of the 17 post-treatment isolates were obtained after treatment with tripotassium dicitrate bismuthate (De-Nol) and metronidazole. All strains of H. pylori had identical biotypes, but exhibited diversity between pairs in their molecular fingerprints. Each of the 17 strain pairs had unique ribopatterns; the pre- and post-treatment isolates in most pairs (16 of 17) were similar or identical, irrespective of metronidazole susceptibility. DNA subtype variants were detected in three patient sets. Although nine post-treatment isolates had acquired resistance to metronidazole, most (six of nine) resembled the pre-treatment isolates in their ribopattern, protein and plasmid profiles. No significant correlation was observed between metronidazole resistance and plasmid content in these H. pylori isolates. Emergence of post-treatment metronidazole-resistant isolates of H. pylori was associated only rarely with colonisation by a novel strain or acquisition of a plasmid and, in most patients, probably resulted from spontaneous emergence of resistance in the original infecting strain.
对来自17名患者的配对幽门螺杆菌分离株的生物型、核糖体RNA基因限制性图谱(核糖体图谱)、全细胞蛋白图谱和质粒图谱进行了检测。每对包括一个治疗前和一个治疗后的分离株;17个治疗后分离株中的9个是在接受枸橼酸铋钾(得乐)和甲硝唑治疗后获得的。所有幽门螺杆菌菌株具有相同的生物型,但在分子指纹图谱上,配对菌株之间表现出多样性。17对菌株中的每一对都有独特的核糖体图谱;大多数配对(17对中的16对)的治疗前和治疗后分离株相似或相同,与甲硝唑敏感性无关。在三个患者组中检测到了DNA亚型变体。虽然9个治疗后分离株对甲硝唑产生了耐药性,但大多数(9个中的6个)在核糖体图谱、蛋白质和质粒图谱方面与治疗前分离株相似。在这些幽门螺杆菌分离株中,未观察到甲硝唑耐药性与质粒含量之间存在显著相关性。治疗后甲硝唑耐药幽门螺杆菌分离株的出现很少与新菌株的定植或质粒的获得有关,在大多数患者中,可能是由于原始感染菌株中耐药性的自发出现。